204 related articles for article (PubMed ID: 27733159)
1. Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study.
Sasso FC; Lascar N; Ascione A; Carbonara O; De Nicola L; Minutolo R; Salvatore T; Rizzo MR; Cirillo P; Paolisso G; Marfella R;
Cardiovasc Diabetol; 2016 Oct; 15(1):147. PubMed ID: 27733159
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study.
Sasso FC; Marfella R; Pagano A; Porta G; Signoriello G; Lascar N; Minutolo R; Carbonara O; Persico M; Piscione F; De Nicola L; Torella R; Paolisso G
Acta Diabetol; 2015 Apr; 52(2):239-47. PubMed ID: 25109286
[TBL] [Abstract][Full Text] [Related]
3. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
[TBL] [Abstract][Full Text] [Related]
4. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
[TBL] [Abstract][Full Text] [Related]
5. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
Fung CSC; Wan EYF; Chan AKC; Lam CLK
BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
[TBL] [Abstract][Full Text] [Related]
6. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study.
Kim JY; Choi J; Kim SG; Kim NH
Cardiovasc Diabetol; 2022 Feb; 21(1):28. PubMed ID: 35193571
[TBL] [Abstract][Full Text] [Related]
7. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
Stam-Slob MC; Visseren FL; Wouter Jukema J; van der Graaf Y; Poulter NR; Gupta A; Sattar N; Macfarlane PW; Kearney PM; de Craen AJ; Trompet S
Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244
[TBL] [Abstract][Full Text] [Related]
8. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
[TBL] [Abstract][Full Text] [Related]
9. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
[TBL] [Abstract][Full Text] [Related]
10. Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study.
Zhu L; Hayen A; Bell KJL
Cardiovasc Diabetol; 2020 Mar; 19(1):28. PubMed ID: 32138746
[TBL] [Abstract][Full Text] [Related]
11. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
13. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
[TBL] [Abstract][Full Text] [Related]
14. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.
Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW
Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Ferdinand KC; Botros FT; Atisso CM; Sager PT
Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
[TBL] [Abstract][Full Text] [Related]
16. Intensity of statin therapy and primary prevention of cardiovascular in Korean patients with dyslipidemia.
Song SO; Kang MJ; Suh S
Medicine (Baltimore); 2024 Mar; 103(11):e37536. PubMed ID: 38489707
[TBL] [Abstract][Full Text] [Related]
17. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
[TBL] [Abstract][Full Text] [Related]
18. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
Sofat S; Chen X; Chowdhury MM; Coughlin PA
Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
[TBL] [Abstract][Full Text] [Related]
19. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
20. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
Zhao B; He X; Wu J; Yan S
BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
